Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
Progyny (NASDAQ: PGNY) will report results for the quarter ended March 31, 2026, after market close on Thursday, May 7, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Progyny (NASDAQ: PGNY) will report results for the quarter ended March 31, 2026, after market close on Thursday, May 7, 2026. A conference call will follow at 4:45 p.m. ET (1:45 p.m. PT). A press release will be issued before the call and a live webcast and archived replay will be available on the investor website.
Details
News Market Reaction – PGNY
On Apr 23, the day this news came out, PGNY closed 1.78% below the previous close.
Data tracked by StockTitan Argus for the Apr 23 session.
Key Figures
- Quarter end date
- March 31, 2026
- Quarterly period covered by upcoming results
- Earnings release date
- May 7, 2026
- Date results will be reported after market close
- Conference call time ET
- 4:45 p.m.
- Scheduled time for Q1 2026 call in Eastern Time
- US dial-in number
- 1.866.825.7331
- Domestic access number for the earnings conference call
- International dial-in
- 1.973.413.6106
- International access number for the earnings conference call
- Passcode
- 265484
- Access code for live call and replay
- Replay end date
- May 14, 2026
- Date through which the audio replay will be available
- Replay US dial-in
- 1.800.332.6854
- US dial-in number to access call replay
Previous Earnings Reports
-
Reported Q4 and FY 2025 results with revenue growth and solid profitability.
-
Announced timing and access details for Q4 and FY 2025 results call.
-
Reported Q3 2025 revenue and EBITDA growth with raised full‑year guidance.
-
Provided reporting date and call logistics for Q3 2025 financial results.
-
Announced strong Q2 2025 revenue, net income, and raised full‑year guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended March 31, 2026, after the close of the market on Thursday, May 7, 2026.
The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Thursday, May 14, 2026, and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.